Northern Trust Portfolio holdings
Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$601M |
| 2 |
Moderna
MRNA
|
+$557M |
| 3 |
Analog Devices
ADI
|
+$448M |
| 4 |
FlexShares Global Upstream Natural Resources Index Fund
GUNR
|
+$445M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$406M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$652M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$512M |
| 3 |
TSMC
TSM
|
+$378M |
| 4 |
JPMorgan Chase
JPM
|
+$318M |
| 5 |
MXIM
Maxim Integrated Products
MXIM
|
+$305M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.12% |
| 2 | Financials | 12.68% |
| 3 | Healthcare | 12.53% |
| 4 | Consumer Discretionary | 11.26% |
| 5 | Communication Services | 9.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3326
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
$9.17B
| $1.86M | ﹤0.01% |
49,308
+5,532
| +13% | +$211K |
|
3327
CEMIG Preferred Shares
CIG
$6.26B
| $1.86M | ﹤0.01% |
1,244,599
-3,189,572
| -72% | -$4.48M |
|
3328
TaskUs
TASK
$556M
| $1.85M | ﹤0.01% |
+27,929
| New | +$1.32M |
|
3329
AgEagle Aerial Systems
UAVS
$40.9M
| $1.85M | ﹤0.01% |
616
-15
| -2% | -$55.7K |
|
3330
ARS Pharmaceuticals
SPRY
$509M
| $1.85M | ﹤0.01% |
185,747
+59,849
| +48% | +$1.48M |
|
|
JBIO
3331
Jade Biosciences
JBIO
$1.2B
| $1.85M | ﹤0.01% |
+2,520
| New | +$1.41M |
|
3332
INNOVATE Corp
VATE
$111M
| $1.85M | ﹤0.01% |
45,118
-2,247
| -5% | -$84K |
|
3333
Wave Life Sciences
WVE
$1.09B
| $1.83M | ﹤0.01% |
374,509
-3,056
| -0.8% | -$18.5K |
|
3334
XP
XP
$8.81B
| $1.83M | ﹤0.01% |
45,566
-33,941
| -43% | -$1.52M |
|
3335
Cadiz
CDZI
$251M
| $1.83M | ﹤0.01% |
259,376
-15,248
| -6% | -$187K |
|
3336
Establishment Labs
ESTA
$2.72B
| $1.83M | ﹤0.01% |
25,512
+1,951
| +8% | +$144K |
|
3337
iShares Currency Hedged MSCI Emerging Markets
HEEM
$276M
| $1.82M | ﹤0.01% |
59,805
| – | – |
|
3338
iShares MSCI China ETF
MCHI
$6.32B
| $1.82M | ﹤0.01% |
+26,950
| New | +$1.94M |
|
3339
Mustang Bio
MBIO
$4.32M
| $1.82M | ﹤0.01% |
901
+30
| +3% | +$64.4K |
|
|
ROVR
3340
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
| $1.82M | ﹤0.01% |
+133,671
| New | +$1.65M |
|
3341
Outlook Therapeutics
OTLK
$183M
| $1.81M | ﹤0.01% |
41,766
-2,255
| -5% | -$109K |
|
|
LTCH
3342
DELISTED
Latch, Inc. Common Stock
LTCH
| $1.81M | ﹤0.01% |
+160,722
| New | +$1.98M |
|
|
BFIN
3343
DELISTED
BankFinancial
BFIN
| $1.81M | ﹤0.01% |
157,660
-14,603
| -8% | -$166K |
|
3344
Vanguard International Dividend Appreciation ETF
VIGI
$9.08B
| $1.81M | ﹤0.01% |
20,713
+5,413
| +35% | +$484K |
|
3345
Design Therapeutics
DSGN
$761M
| $1.8M | ﹤0.01% |
122,832
-12,695
| -9% | -$211K |
|
3346
Fidelity D&D Bancorp
FDBC
$306M
| $1.8M | ﹤0.01% |
35,725
-1,423
| -4% | -$74.8K |
|
3347
Mistras Group
MG
$484M
| $1.8M | ﹤0.01% |
177,168
-6,944
| -4% | -$68.5K |
|
3348
Banco Santander Chile
BSAC
$16.3B
| $1.78M | ﹤0.01% |
90,100
-192,051
| -68% | -$3.78M |
|
3349
Universal Logistics Holdings
ULH
$353M
| $1.77M | ﹤0.01% |
88,317
-7,853
| -8% | -$170K |
|
3350
Mirum Pharmaceuticals
MIRM
$6.46B
| $1.77M | ﹤0.01% |
88,745
-7,233
| -8% | -$118K |
|
Similar funds
Northern Trust's Q3 2021 Portfolio in Review
As of Q3 2021, Northern Trust held 4,828 positions worth $565B, down 0.48% from $568B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Northern Trust's Q3 2021 filing shows 242 new, 1,428 increased, 2,705 reduced and 176 closed positions. Its largest new stake was Dimensional International Value ETF: 4,656,805 shares worth $152M. The largest sale was Alphabet (Google) Class C, an estimated $652M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.
- Northern Trust's largest Q3 2021 buy was Dimensional International Value ETF: 4,656,805 shares worth $152M.
- Northern Trust added most to Johnson & Johnson in Q3 2021, an estimated $601M increase.
- Northern Trust's biggest Q3 2021 reduction was Alphabet (Google) Class C, cutting an estimated $652M.
- Northern Trust fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $512M.
- Northern Trust's ten largest holdings make up 22% of its $565B portfolio in Q3 2021.
- Northern Trust opened 242 new positions and closed 176 in Q3 2021.
- Northern Trust's portfolio value fell 0.48% quarter-over-quarter to $565B.
Based on Northern Trust's 13F filing for Q3 2021, filed 15 Nov 2021.